1. Home
  2. AYTU vs CJET Comparison

AYTU vs CJET Comparison

Compare AYTU & CJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • CJET
  • Stock Information
  • Founded
  • AYTU N/A
  • CJET 2009
  • Country
  • AYTU United States
  • CJET China
  • Employees
  • AYTU N/A
  • CJET N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • CJET Auto Manufacturing
  • Sector
  • AYTU Health Care
  • CJET Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • CJET Nasdaq
  • Market Cap
  • AYTU 10.7M
  • CJET 11.1M
  • IPO Year
  • AYTU N/A
  • CJET N/A
  • Fundamental
  • Price
  • AYTU $1.51
  • CJET $1.95
  • Analyst Decision
  • AYTU
  • CJET
  • Analyst Count
  • AYTU 0
  • CJET 0
  • Target Price
  • AYTU N/A
  • CJET N/A
  • AVG Volume (30 Days)
  • AYTU 45.2K
  • CJET 14.9K
  • Earning Date
  • AYTU 11-13-2024
  • CJET 12-02-2024
  • Dividend Yield
  • AYTU N/A
  • CJET N/A
  • EPS Growth
  • AYTU N/A
  • CJET N/A
  • EPS
  • AYTU N/A
  • CJET N/A
  • Revenue
  • AYTU $79,759,000.00
  • CJET $10,275,000.00
  • Revenue This Year
  • AYTU N/A
  • CJET N/A
  • Revenue Next Year
  • AYTU $2.35
  • CJET N/A
  • P/E Ratio
  • AYTU N/A
  • CJET N/A
  • Revenue Growth
  • AYTU N/A
  • CJET 31.31
  • 52 Week Low
  • AYTU $1.41
  • CJET $1.77
  • 52 Week High
  • AYTU $3.45
  • CJET $57.60
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 26.32
  • CJET 41.87
  • Support Level
  • AYTU $1.41
  • CJET $1.82
  • Resistance Level
  • AYTU $1.63
  • CJET $2.13
  • Average True Range (ATR)
  • AYTU 0.21
  • CJET 0.18
  • MACD
  • AYTU -0.01
  • CJET 0.00
  • Stochastic Oscillator
  • AYTU 11.98
  • CJET 21.67

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About CJET Chijet Motor Company Inc.

Chijet Motor Co Inc is engaged in the research and development, production and sales of new energy vehicles. New energy vehicles refer to plug-in electric vehicles including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans.

Share on Social Networks: